OTC · ETRGF
Entourage Health Corp.
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
Loading market information…
OTC · NUTTQ · USD
Stock price, earnings
Quote as of May 7, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nutroganics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nutroganics, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nutroganics, Inc.'s primary business strategy involved acquiring and overseeing profitable companies within the healthy lifestyle industry, focusing heavily on nutritional supplements and the natural and organic food markets. One of its key operational entities was Silverbow Honey Company, a subsidiary that handled the production, packaging, and sale of various honey products. These goods were supplied to food manufacturers and prominent national grocery chains, marketed under both the Silverbow brand and as private label offerings. The company was based in Bethesda, Maryland. However, a significant development occurred on October 14, 2016, when Nutroganics, Inc. and its affiliated organizations filed a voluntary petition for Chapter 7 liquidation with the US Bankruptcy Court for the District of Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Jun 3, 1996 |
| $0.13+8.33% vs estimate |
| $0.00 |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
$0.16$0.00 (0.0%)
RegenETP, Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.93% below the high.
$0.01+$0.01 (+316.67%)
Novation Companies, Inc.: Healthcare · Medical - Care Facilities.
$0.37+$0.04 (+12.12%)
InVivo Therapeutics Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.76% below the high.
$0.01+$0.00 (+4.0%)
Digipath, Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.14% below the high.
$0.00$0.00 (0.0%)
Suvanza Pharma, LLC’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
American Caresource Holdings, Inc.: Healthcare · Medical - Care Facilities.
$0.00+$0.00 (+100.0%)
China BCT Pharmacy Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
